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Abstract
The recognition of pathogen-derived structures by C-type lectins and the chemotactic activity mediated by the CCL2/CCR2
axis are critical steps in determining the host immune response to fungi. The present study was designed to investigate
whether the presence of single nucleotide polymorphisms (SNPs) within DC-SIGN, Dectin-1, Dectin-2, CCL2 and CCR2 genes
influence the risk of developing Invasive Pulmonary Aspergillosis (IPA). Twenty-seven SNPs were selected using a hybrid
functional/tagging approach and genotyped in 182 haematological patients, fifty-seven of them diagnosed with proven or
probable IPA according to the 2008 EORTC/MSG criteria. Association analysis revealed that carriers of the Dectin-1rs3901533 T/T
and Dectin-1rs7309123 G/G genotypes and DC-SIGNrs4804800 G, DC-SIGNrs11465384 T, DC-SIGN7248637 A and DC-SIGN7252229 C alleles
had a significantly increased risk of IPA infection (OR=5.59 95%CI 1.37–22.77; OR=4.91 95%CI 1.52–15.89; OR=2.75 95%CI
1.27–5.95; OR=2.70 95%CI 1.24–5.90; OR=2.39 95%CI 1.09–5.22 and OR=2.05 95%CI 1.00–4.22, respectively). There was
also a significantly increased frequency of galactomannan positivity among patients carrying the Dectin-1rs3901533_T allele
and Dectin-1rs7309123_G/G genotype. In addition, healthy individuals with this latter genotype showed a significantly
decreased level of Dectin-1 mRNA expression compared to C-allele carriers, suggesting a role of the Dectin-1rs7309123
polymorphism in determining the levels of Dectin-1 and, consequently, the level of susceptibility to IPA infection. SNP-SNP
interaction (epistasis) analysis revealed significant interactions models including SNPs in Dectin-1, Dectin-2, CCL2 and CCR2
genes, with synergistic genetic effects. Although these results need to be further validated in larger cohorts, they suggest
that Dectin-1, DC-SIGN, Dectin-2, CCL2 and CCR2 genetic variants influence the risk of IPA infection and might be useful in
developing a risk-adapted prophylaxis.
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Introduction
Invasive Pulmonary Aspergillosis (IPA) is a life-threatening
infection caused mainly by Aspergillus fumigatus, an opportunistic
fungal pathogen that frequently colonizes respiratory tracts and
rapidly spreads to blood vessels and tissues [1]. The incidence of
IPA infection has increased in the last years due to the use of
immunosuppressive and immunomodulatory drugs and is still
causing significant morbidity and mortality worldwide, especially
in immunosuppressed and hematopoietic stem cell transplantation
(HSCT) patients [2].
Early recognition of A. fumigatus by myeloid leukocytes is a
crucial for down-stream immune response and conidia clearance
and, therefore, in the development and progression of IPA
infection [3]. Myeloid leukocytes are activated by pattern-
recognition receptors (PRRs), which directly recognize fungal cell
wall structures and pathogen-associated molecular patterns
(PAMPs) [4]. Among the PRRs expressed in neutrophils,
pulmonary macrophages and dendritic cells, C-type lectin family
members such as DC-SIGN (Dendritic Cell-Specific Intercellular
adhesion molecule-3-Grabbing Non-integrin), Dectin-1 (Dendritic
cell-associated C-type lectin-1) and Dectin-2 (Dendritic cell-
associated C-type lectin-2) seem to be important in the
effectiveness of innate immune response against A. fumigatus
[5,6]. Recent studies have reported that the C-type lectins mediate
A. Fumigatus recognition, capture and internalization [7] and that
their binding to fungal cell wall carbohydrates is highly specific
and selective [8]. DC-SIGN and Dectin-1 recognize b-(1-3)-glucans
and galactomannans (GM) in the cell wall of A. fumigatus [7,9]
while Dectin-2 interacts with a-mannans [10]. However, numerous
studies have shown that C-type lectins are not only involved in the
recognition of fungal pathogens but also in the induction of anti-
fungal Th1 and Th17 immune responses [5,11].
Although the mechanisms underlying DC-SIGN-mediated
immune response are still highly speculative, it has been suggested
that DC-SIGN promotes dendritic cell (DC) migration and T-cell
activation through the ICAM-3 binding [12,13] and modulates
TLR signalling by targeting Raf-1, which regulates NFkB p65
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cytokines [14]. Likewise, Dectin-1 and Dectin-2 induce Syk-
dependent canonical and noncanonical NFkB pathways [15,16]
promoting the production of some pro-inflammatory cytokines
(IL1a, IL1b, IL12 and IL8), chemokines (CCL2/MCP-1, CCL3/
MIP-1, CXCL2/MIP-2 and CXCL10) [17] and the IL17-mediated
neutrophil recruitment [18]. It has also been described that Dectin-
1 and Dectin-2 are able to work in collaboration with TLRs (mainly
TLR2, TLR4 and TLR6) modulating immune responses through
the production of IL6, IL12p70 and TNF [3,16]. These findings
support the hypothesis that C-type lectins, cytokines or chemo-
kines are important mediators during infection with A. fumigatus.
Several polymorphisms in human PRRs [19–24] as well as in
some cytokines [25–27], chemokines [28] and their receptors
[29,30] have hitherto been associated with an increased risk of
invasive aspergillosis in susceptible hosts. Based on these
observations, the objective of the present study was to investigate
the role of tagging and potentially functional single-nucleotide
polymorphisms (SNPs) located within the DC-SIGN, Dectin-1,
Dectin-2, MCP-1/CCL2 and CCR2 genes on IPA susceptibility.
Materials and Methods
Study population and clinical diagnosis of IPA infection
All participants enrolled were Caucasian and recruited in the
University Hospital Virgen de las Nieves (Granada, Spain) or in
the University Hospital of Salamanca (Salamanca, Spain). All
determinations and genetic analyses in hematological patients
were performed with fully informed written consent, and
anonymity of the data was guaranteed. The study protocol was
approved by the Ethical Review Committee of Virgen de las
Nieves University Hospital, Granada, Spain. The population
included 182 hematological patients recruited between January
2004 and January 2011. All hematological patients in this study
received a prolonged chemotherapy treatment or underwent
HSCT and were therefore considered susceptible to develop IPA
infection. Demographic information and clinical data were
obtained by detailed review of hospital records. Data were
gathered on: site of infection; host factor criteria (severe
neutropenia for .10 days, persistent fever for .96 h refractory
to appropriate broad-spectrum antibacterial treatment, signs and
symptoms indicating graft-versus-host disease [GVHD], corticoid
therapy [.0.3 mg/kg per day], and invasive fungal infection
during a previous episode of neutropenia), microbiological criteria
(positive result for Aspergillus antigen in $2 consecutive blood
samples when considering an index of 0.5 or in only 1 sample
when the index was higher than 0.8), and clinical criteria of lower
respiratory tract infection [major criteria: any of the following new
infiltrates on computed tomography (CT) imaging: halo sign, air-
crescent sign, or cavity within area of consolidation; minor criteria:
cough, thoracic pain, hemoptysis, pathologic pulmonary sound,
and radiological evidence suggestive of invasive infection].
Laboratory data were also recorded. Proven and probable IPA
was diagnosed based on the updated criteria (2008) reported by
the European Organization for Research and Treatment of
Cancer/Invasive Fungal Infections Cooperative Group (EORTC/
IFICG) [31].
Quantification of serum galactomannan antigen
Serum GM detection has been shown to be a useful test for the
early diagnosis and follow-up of IPA and is now included in IPA
diagnosis criteria [31]. In the present study, serum GM antigen
was determined twice weekly during the hospital stay and at each
outpatient visit until the end of their immunosuppressant or
chemotherapeutic treatment. Serum GM concentrations were
determined by Platelia Aspergillus ELISA kit (Bio-Rad, Marnes-la-
Coquette, France) according to the manufacturer’s instructions.
This commercial kit has proven to offer good sensitivity to detect
GM [32], and GM concentration was found to correlate with the
fungal tissue burden [33,34]. A test sample was classified as
positive when the optical density ratio was $0.5 in two consecutive
positive samples or .0.8 in a unique serum sample. A careful
review of concomitant treatments (piperacillin-tazobactam or
amoxicillin-clavulonic acid) in each patient was necessary to
detect possible false-positive GM determinations. Likewise, tests
were performed on the same day to avoid sample contamination
and to ensure accuracy of results.
SNP selection and genotyping
Twenty-seven tagging/functional SNPs within DC-SIGN, Dectin-
1, Dectin-2, CCL2 and CCR2 were selected to genotype the entire
panel of individuals (Table 1). The aim of the SNP tagging was to
identify a set of SNPs that efficiently tags all the known SNPs while
the functional approach was used to determine the net impact of
potentially functional variants within DC-SIGN, Dectin-1, Dectin-2,
CCL2 and CCR2 genes on IPA risk. Tagging SNPs were selected
using Haploview Tagger program (http://www.broad.mit.edu/
mpg/haploview/; http://www.broad.mit.edu/mpg/tagger/) and
a pairwise tagging with a minimum r2 of 0.8. In this selection we
forced the inclusion of the DC-SIGNrs4804803, CCL2rs1024610 and
CCL2rs1024611 polymorphisms as their functionality has been
suggested [35–37]. Genomic DNA was extracted from peripheral
blood mononuclear cells (PBMCs) Qiagen Mini Kit (Qiagen,
Valencia, CA, USA). Genotyping of DC-SIGN, Dectin-1, Dectin-2,
CCL2 and CCR2 polymorphisms was carried out using KASPar
assays (KBiosciences, Hoddesdon, Hertfordshire, UK) in a 384-
well plate format (Applied Biosystems, Foster City, CA, USA)
where hematological patient samples were randomly distributed.
KASPar reactions were performed using KASPar assay mix
(containing probes) and KASPar kit containing 26Reaction Mix
and MgCl2 (50 mM). PCR conditions were: denaturation at 94uC
for 15 min, 10 cycles of denaturation at 94uC for 10 sec,
annealing at 57uC for 5 sec and elongation at 72uC for 10 sec
and 20 cycles of denaturation at 94uC for 10 sec, annealing at
57uC for 20 sec and elongation at 72uC for 40 sec. Recycling
conditions were 94uC for 10 sec, annealing and elongation at
60uC for 60 sec. PCR products were analyzed with the ABI Prism
7900HT detection system using the SDS 2.4 software (Applied
Biosystems). For internal quality control, about 5% of samples
were randomly selected and included as duplicate. Concordance
between the original and the duplicate samples for the 27 SNPs
analyzed was $99.5%. Call rates for all SNPs were $97.8% with
the exception of the Dectin-1rs11053599 SNP with a call rate of
94.5%.
Statistical analysis
The Hardy-Weinberg Equilibrium (HWE) tests were performed
in the control group (non-IPA patients) by a standard observed-
expected chi-square (x
2) test at each polymorphic site (http://ihg2.
helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl). Unconditional lo-
gistic regression was used to assess the main effects of the genetic
polymorphisms on IPA risk using co-dominant, dominant and
recessive inheritance models. For each SNP, the more common
allele in the control group was assigned as the reference category.
All analyses were adjusted for age, gender, hematological
malignancy and established risk factors for IPA infection (HSCT,
neutropenia, GVHD and corticoid therapy use) and were
conducted using the statistical software SSPS (version 14.0, SPSS
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Gene and
SNP position dbSNP rs# Location Aa change
Nucleotide
substitution
Hypothetical function
and/or reported associations Reference
DC-SIGN_c.2139 rs2287886 Promoter - A/G Affects transcriptional activity and
DC-SIGN mRNA expression level;
associated with protection against
IPA infection; associated with several
infection and immune-related diseases
such as HIV-1, Dengue, TB, parenteral
infection, SARS, RA.
Sainz et al. 2010; Chang et al.
2010; Koizumi et al. 2007;
Mezger et al. 2008;
Kashima et al. 2009; Martin et
al. 2004;
Go ´mez et al. 2006
DC-SIGN_c.2336 rs4804803 Promoter - A/G Affects transcriptional activity and
DC-SIGN mRNA expression; associated
with risk of parenteral infection, HIV-1,
HCV, dengue and tuberculosis.
Sakuntabhai et al. 2005;
Martin et al. 2004
Barreiro et al. 2006; Ryan et al.
2010
DC-SIGN_c.2797 rs4804800 39-UTR - A/G 39-UTR affecting RNA expression -
DC-SIGN_c.342+2863 rs8112310 59 near gene - A/T Potential activity affecting
DC-SIGN expression
-
DC-SIGN_IVS6 2326 rs10410342 Intron - C/G Unknown -
DC-SIGN_ c.749228 rs11465384 39-UTR - C/T 39-UTR affecting
RNA expression
-
DC-SIGN_ c.1974 rs11465413 39-UTR - A/T 39-UTR affecting
RNA expression
-
DC-SIGN_IVS2+11 rs7252229 Intron - G/C Unknown -
DC-SIGN_c.898 rs7248637 39-UTR - A/G 39-UTR affecting RNA expression -
DC-SIGN_c.2629 rs11465421 39-UTR - A/C 39-UTR affecting RNA expression -
Dectin-1
(CLEC7A)_c.714
rs16910526 Coding exon Y238X A/C Defective expression and lack
of b-glucan recognition by
Phagocytes; associated with increased
Aspergillus and Candida colonization in
hematopoietic transplant recipients
Ferwerda et al. 2009
Cunha et al. 2010; Platinga et
al. 2009
Dectin-1
(CLEC7A)_c.37521148
rs11053599 Intron - A/C Unknown -
Dectin-1
(CLEC7A)_c.37521404
rs7309123 Intron - C/G Unknown -
Dectin-1
(CLEC7A)_c.255+813
rs3901533 Intron - G/T Unknown -
Dectin-1
(CLEC7A)_c.1042520
rs4763446 Intron - C/T Unknown -
Dectin-1
(CLEC7A)_c.1042811
rs16910631 Intron - C/T Unknown -
Dectin-1
(CLEC7A)_c.103+732
rs7311598 Intron - A/G Unknown -
Dectin-2
(CLEC6A)_c.369+338
rs7134303 Intron - A/G Unknown -
Dectin-2
(CLEC6A)_c.1222425
rs4264222 Intron - C/T Unknown -
Dectin-2
(CLEC6A)_c.322699
rs4459385 Intron - C/T Unknown -
CCL2 (MCP-1)_c.903 rs4586 Coding exon C35C C/T Associated with an increased risk of TB Thye et al. 2009
CCL2 (MCP-1)_c.22136 rs1024610 Promoter - A/T Unknown -
CCL2 (MCP-1)_c.22518 rs1024611 Promoter - C/T Correlate with MCP-1 mRNA expression;
associated with increased risk to TB,
HCV and HBV infections
Ganachari et al. 2010; Park et
al. 2006;
Flores-Villanueva et al. 2005;
Mu ¨hlbauer et al. 2003
CCL2 (MCP-1)_c.1543 rs13900 39-UTR - C/T Unknown -
CCR2 _c.21221 rs3918358 Promoter - A/C Unknown -
CCR2 _c.667 rs743660 39-UTR - A/G Associated with a decreased risk of Asthma Kim et al. 2007
CCR2_Ex2+241 rs1799864 Coding exon V64I A/G Associated with slower progression to HIV Smith et al. 1997
Abbreviations: UTR, untranslated region; TB, Tuberculosis; HCV, Hepatitis C virus; HBV, Hepatitis B virus; HIV-1, Human immunodeficiency virus-1; SARS, acute severe
respiratory syndrome; RA, Rheumatoid arthritis.
doi:10.1371/journal.pone.0032273.t001
Dectin-1 and DC-SIGN SNPs and IPA Infection
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e32273Inc., Chicago, USA). All tests were considered to be statistically
significant with a p value of ,0.05.
Adjustment for multiple testing was carried out following a
conservative threshold for statistical significance, based on a
revised version of the Bonferroni method: we calculated for each
gene the ‘‘number of effective independent variables’’ (Meff) by use
of the SNP Spectral Decomposition approach (http://gump.qimr.
edu.au/general/daleN/SNPSpDsuperlite/) [38]. We obtained a
study-wise Meff value by adding up the gene Meff’s.
SNPtool (http://www.dkfz.de/de/molgen_epidemiology/tools/
SNPtool.html) [39] and the Haploview v4.2 software were used for
LD blocks reconstruction and haplotype association statistics. Block
structures were determined according to the method of Gabriel et
al. [40].
Functional prediction of associated SNPs
We used the Web-based tool FastSNP [41] available at http://
fastsnp.ibms.sinica.edu.tw for predicting the functional significance
of the SNPs associated with IPA infection. FastSNP utilizes
information from another online program PolyPhen (http://www.
bork.embl-heidelberg.de/PolyPhen/) and from four different web
resources (TFSearch, ESEfinder, Rescue-ESE and FAS-ESS) to
determine whether SNPs are located at exonic splicing regulatory
sites, cause a non-conservative amino acid change or whether they
alter the transcription factor-binding site of a gene (for instance,
acting as intronic enhancer). The score was given by this tool on
the basis of levels of risk with a ranking of 0 (no effect), 1 (very low),
2 (low), 3 (medium), 4 (high), or 5 (very high).
RNA extraction, reverse transcription, and qPCR
Whole blood samples from 21 healthy donors were collected
into PAXGENE RNA tubes and stored at 280uC until use. Total
RNAs were extracted using a PAXGENE Blood RNA Isolation
Kit (PreAnalytiX) and reverse transcribed to cDNA using
QuantiTect Reverse Transcription Kit (catalog number: 205311;
Qiagen). Real-time quantitative PCR was carried out using an
ABI PRISMH 7500 HT Sequence Detection System (Applied
Biosystems) according to manufacturer’s instructions. Briefly, 2 ml
of the cDNA were loaded in a PCR reaction containing 12.5 mlo f
26 QuantiTect SYBR Green PCR Master Mix with an
appropriate concentration of MgCl2, 2.5 ml of primers (Hs_CLE-
C7A_1_SG QuantiTect Primer Assay, catalog number:
QT00024059; Geneglobe, Qiagen) and 8 ml of RNase-free water.
PCR cycling conditions were as follows: 95uC for 15 minutes,
followed by 40 cycles of denaturation at 95uC for 15 seconds
combined with annealing at 60uC for 30 seconds and extension at
72uC for 30 seconds. All samples were run in duplicate. Relative
quantification of Dectin-1 mRNA expression was calculated with
the 2
2DDCt method. We obtained the fold changes in gene
expression normalized to an internal control gene (GAPDH,
Hs_GAPDH_2_SG QuantiTect Primer Assay, Catalog number:
QT01192646; Qiagen) and relative to one calibrator (First-
Table 2. Demographic and clinical data of IPA and non-IPA patients.
Patients with IPA (n=57) Patients without IPA (n=125) { P values
Demographic variables
Age (range) 48.98 (16-76) 50.95 (16-78) NS
Sex ratio (male/female) 35/22 70/55 NS
Hematological disease (%)
AML 27 (47.37) 41 (32.80)
ALL 9 (15.79) 12 (9.60)
MM 4 (7.02) 20 (16.00)
CML 0 (0.00) 2 (1.60)
HL 2 (3.51) 15 (12.00)
NHL 8 (14.03) 23 (18.40)
AA 3 (5.26) 2 (1.60)
CLL 2 (3.51) 6 (4.80)
MDS 2 (3.51) 4 (3.20)
EORTC/MSG 2008 classification
Proven IPA 13 (22.80) -
Probable IPA 44 (77.20) -
Risk factors
HSCT 33 (57.90) 53 (42.4) NS
Severe neutropenia{ 45 (78.95) 105 (84.00) NS
Corticoid therapy 14 (24.56) 40 (32.00) NS
GVHD 8 (14.04) 11 (8.80) NS
Abbreviations: NS, non-significant. HSCT: Hematopoietic stem cell transplantation, AML: acute myeloid leukemia, ALL: acute lymphoid leukemia, MM: Multiple Myeloma,
CML: chronic myeloid leukemia, HL: Hodgekin’s lymphoma, NHL: non-Hodgekin’s lymphoma, AA: Aplastic anemia, CLL: chronic lymphocytic leukemia, MDS:
myelodysplastic syndrome.
{: Severe neutropenia was defined as absolute neutrophil count ,500 cells/mm
3 for a period of more than 12 days. GVHD: graft versus host disease;
{: p-values were calculated by student-t test for continous- and Fishers exact test for binary data.
doi:10.1371/journal.pone.0032273.t002
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Applied Biosystems).
SNP-SNP interaction analysis
We also analyzed high-order interactions between SNPs using
the multifactor dimensionality reduction (MDR) constructive
induction algorithm. A detailed explanation on the MDR method
has been described elsewhere [42,43]. SNPs in LD (cut-off of
r
2,0.8) were excluded from the MDR analysis. Cross-validation
and permutation testing were used to identify the best models. All
possible two-, three- and four-way SNP interactions were tested
using 100-fold cross-validation and the exhaustive search. The
model with the highest testing balanced accuracy (TA) and cross
validation consistency (CVC) was selected as ‘‘best model’’.
Statistical significance was evaluated using a 1.000-fold permuta-
tion test to compare observed testing balanced accuracies with
those expected under the null hypothesis of no association (using
the MDR permutation testing module 0.4.9 alpha). MDR results
were considered statistically significant at the 0.05 level. Finally,
interactions were visualized by constructing an interaction
dendrogram according to the method described by Moore et al
[43]. MDR software and MDR permutation testing module are
open-source and freely available from http://www.epistasis.org.
Results
Population characteristics are described in Table 2. Compared
to non-IPA, IPA cases were more likely to have cough and
pathologic pulmonary sound (p,0.001 and 0.011, respectively)
and presented more often pathological chest radiographies and
CT scans (p,0.001). Established risk factors for IPA infection such
as HSCT, neutropenia, GVHD and corticoid therapy use were
homogenously distributed between IPA and non-IPA patient
groups.
Fifty-seven patients were diagnosed with proven or probable
IPA infection according to the revised EORTC/MSG criteria
(2008). The association of risk of IPA infection with the individual
Table 3. DC-SIGN and Dectin-1 polymorphisms associated with susceptibility to Invasive Pulmonary Aspergillosis.
Gene_rs number Genotype IPA patients (%) Non-IPA patients (%) OR (95% CI)
1 P-value P-trend
DC-SIGN_rs4804800 A/A 32 (56.1) 91 (72.8) 1.00
A/G 21 (36.8) 31 (24.8) 2.61 (1.17–5.86)
G/G 4 (7.0) 3 (2.4) 3.82 (0.68–21.50) 0.031
A/G+G/G 25 (43.9) 34 (27.2) 2.75 (1.27–5.95) 0.009
per G allele 2.29 (1.21–4.35) 0.01
DC-SIGN_rs11465384 C/C 36 (63.2) 99 (79.2) 1.00
C/T 21 (36.8) 25 (20.0) 2.80 (1.27–6.15)
T/T 0 (0.0) 1 (0.8) 0.00 (0.00–NA) 0.029
C/T+T/T 21 (36.8) 26 (20.8) 2.70 (1.24–5.90) 0.012
per T allele 2.45 (1.16–5.17) 0.019
DC-SIGN_rs7248637 G/G 35 (62.5) 95 (76.6) 1.00
G/A 19 (33.9) 25 (20.2) 2.46 (1.09–5.58)
A/A 2 (3.6) 4 (3.2) 1.90 (0.27–13.41) 0.088
G/A+A/A 21 (37.5) 29 (23.4) 2.39 (1.09–5.22) 0.028
per A allele 1.94 (1.01–3.74) 0.047
DC-SIGN_rs7252229 G/G 30 (51.4) 79 (63.7) 1.00
G/C 27 (47.1) 41 (33.1) 2.50 (1.19–5.29)
C/C 0 (0.0) 4 (3.2) 0.00 (0.00–NA) 0.004
G/C+C/C 27 (47.1) 45 (36.3) 2.05 (1.00–4.22) 0.049
per C allele 1.49 (0.78–2.84) 0.22
Dectin-1_rs3901533 G/G 35 (61.4) 77 (60.7) 1.00
G/T 14 (24.6) 43 (33.9) 0.57 (0.24–1.36)
T/T 8 (14.0) 5 (5.4) 5.59 (1.37–22.77) 0.012
G/G+G/T 49 (86.0) 120 (96.0) 6.30 (1.56–25.37) 0.007{
per T allele 1.39 (0.80–2.42) 0.25
Dectin-1_rs7309123 C/C 23 (40.4) 49 (39.2) 1.00
C/G 21 (36.8) 66 (52.8) 0.81 (0.36–1.82)
G/G 13 (22.8) 10 (8.0) 4.91 (1.52–15.89) 0.005
C/C+C/G 44 (77.2) 115 (92.0) 5.52 (1.86–16.39) 0.001{
per G allele 1.75 (1.01–3.01) 0.042
1Models adjusted for age, gender, hematological malignancy, HSCT, neutropenia (defined as absolute neutrophil count ,500 cells/mm3 for a period of more than 10
days), GVHD and corticoid therapy use (.0.3 mg/Kg/day).
{Assuming a recessive model of inheritance. Abbreviations: OR, odds ratio; CI, confidence interval. Differences in samples numbers are due to failures in genotyping.
doi:10.1371/journal.pone.0032273.t003
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Table S1. All analyzed polymorphisms fulfilled Hardy-Weinberg
expectations for the control group (non-IPA patients).
Several polymorphisms were found to be associated with IPA
infection (Table 3). The Dectin-1rs3901533, Dectin-1rs7309123 and DC-
SIGNrs4804800 polymorphisms showed the strongest association
with risk of IPA infection (ORT/T=5.59, 95%CI1.37–22.77;
ORG/G=4.91, 95%CI1.52–15.89 and ORA/G+G/G=2.75,
95%CI 1.27–5.95, respectively). Additionally, carriers of the DC-
SIGNrs11465384_T, DC-SIGN7248637_A and DC-SIGN7252229_C alleles
had a significantly increased risk of IPA infection (ORC/T+T/
T=2.70, 95%CI 1.24–5.90; ORG/A+A/A=2.39, 95%CI 1.09–
5.22; ORG/C+C/C=2.05, 95%CI 1.00–4.22, respectively) whereas
patients carrying the DC-SIGNrs2287886_A allele showed a tendency
to be associated with a decreased risk of IPA infection (per-allele
OR=0.60, 95%CI 0.34–1.05) (Table 3 and Table S1). After
correction for multiple testing using SNPSpD (number of
independent marker loci, 21; p=0.05/21=0.002), none of the
SNPs retained significance although Dectin-1rs7309123 showed
significance when the carrier status was analyzed (CC+CG vs. GG,
P=0.001; Table 3).
In order to assess the degree to which the selected SNPs and the
positivity of GM correlated, we also performed lineal regression
analysis. In the whole population, 3784 assays were performed in
duplicate and 531 were considered as positive (14.03%). We found
a significantly higher percentage of positive GM among patients
carrying the Dectin-1rs3901533_T allele and among those patients
bearing the Dectin-1rs7309123_G/G genotype suggesting a role of
these polymorphisms in determining a defective recognition and
clearance of Aspergillus conidia (Figure 1). No correlation was
observed for the polymorphisms within DC-SIGN that were
associated with the infection.
We subsequently assessed whether SNPs associated with IPA
infection showed capacity to change putative transcription factor
binding sites using FastSNP. The predictive functional analysis
suggested an intronic enhancer function for the Dectin-1rs7309123
SNP due to its location in transcription factor Cdxa (caudal type
homeo-box transcription factor 1) binding site (GAAAGAC; score
1–2). These data suggest a central role of the rs7309123 in the
susceptibility to IPA infection. None of the remaining SNPs
associated with IPA infection was predicted to affect transcription
factor binding sites or splicing or to introduce a damaging amino
acid change.
To explore the potential consequences of Dectin-1rs7309123 SNP,
Dectin-1 mRNA expression was measured in 21 healthy donors
and was correlated with genotypes. Our results showed that
subjects harbouring GG genotype showed a significantly decreased
level of Dectin-1 mRNA expression compared to C-allele carriers
(p,0.001; Figure 2). These results further supported our
hypothesis suggesting that Dectin-1rs7309123_G allele may disrupt
binding sites for potential transcription factors.
Figure 1. Distribution of positive galactomannan percentage by DC-SIGN and Dectin-1 genotypes.
doi:10.1371/journal.pone.0032273.g001
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significant interactions. Two SNPs (rs1024611 and rs4264222)
were excluded from the MDR analysis as they were in LD with
other SNPs using a cut-off value of r
2,0.80 in our sample set. The
best interaction models selected by the TuRF filter algorithm
along with its testing accuracy and cross-validation consistency are
shown in Table 4. The overall best model with the highest cross-
validation consistency (CVC) consisted of a model that included
the CCL2rs4586, Dectin-1rs3901533, CCR2rs3918358 and Dectin-2rs7134303
SNPs. This model had a significant testing accuracy of 0.7735
(permutation p,0.001) and a cross-validation consistency of 100/
100. Of note is that two SNPs showing genetic interaction in this
model were not significantly associated with an increased risk of
IPA infection in the univariate analysis (CCR2rs3918358 and Dectin-
2rs7134303). The best two-locus model consisted of the Dectin-
1rs3901533 and DC-SIGNrs4804800 SNPs, two variants that showed
also association in the single-locus analysis. This model had a
testing accuracy of 0.6409 and a cross-validation consistency of
76/100. This model was not any more significant after 1.000-fold
permutation testing. However, the entropy based information gain
calculated for this pair of SNPs indicated strong synergy, which
may be interpreted as the two SNPs acting together to increase the
risk of IPA infection. The best three-locus model included the
CCL2rs4586, Dectin-1rs3901533 and Dectin-2rs7134303 SNPs. In this
model, testing accuracy raised to 0.7085 (permutation p=0.025)
whereas the cross-validation consistency was of 68/100. Figure 3
illustrates an interaction dendogram that summarizes the estimates
of interactions.
Discussion
The marked differences in susceptibility to IPA infection among
hematological patients (with or without allo-HSCT) suggest that
the effective immune response against Aspergillus is determined by
both environmental and host genetic factors [44,45]. Studies on
genetic polymorphisms in genes coding for components of the
innate immunity have supported this hypothesis [19,23–30,46].
In this report, we studied the influence of the tagging and
potentially functional polymorphisms of DC-SIGN, Dectin-1, Dectin-
2, CCL2/MCP-1 and CCR2 in susceptibility to IPA infection in a
Spanish population. Polymorphisms in these genes have been
reported to influence a number of infectious diseases including
HIV-1 [47–49], HTLV-1 [50], CMV [51], Tuberculosis [52–55],
HCV [56,57], HBV [58], Dengue [35] and SARS [59] among
others, revealing their potential role in host defense against
pathogens.
We found that polymorphisms in Dectin-1 (rs3901533 and
rs7309123) and DC-SIGN (rs4804800, rs11465384, rs7248637 and
rs7252229) were associated with an increased risk to develop IPA
infection, which points towards their critical involvement in the
pathogenesis of this invasive fungal infection. The highest risk of
IPA infection was found for carriers of the Dectin-1rs3901533_T/T
and Dectin-1rs7309123_G/G genotypes and the DC-SIGNrs4804800_G
allele. Patients carrying these genotypes/alleles had from 2 to 6
times increased risk of IPA infection. Additionally, patients
carrying the DC-SIGNrs11465384_T, DC-SIGN7248637_A and DC-
SIGNrs7252229_C alleles showed a 2-fold increased risk in compar-
ison with patients harboring the wild-type allele. Although it was
not statistically significant, we also found that the DC-SIGNrs2287886
SNP may be associated with a reduced risk of IPA infection.
Interestingly, this latter result was in agreement with our
Figure 2. Correlation between Dectin-1rs7903123 genotype and
expression of Dectin-1 as measured by quantitative PCR in total
RNA from healthy donors (n=21). Dectin-1 mRNA levels were
normalized for GAPDH mRNA levels. FirstChoiceHHuman Brain Refer-
ence RNA was used as Calibrator (Ambion; Catalog number AM6050).
doi:10.1371/journal.pone.0032273.g002
Table 4. Multifactor dimensionality reduction analysis summary.
Model TA P-value* CVC
1 MCP-1_rs4586 0.5881 NS 59/100
2 Dectin-1_rs3901533, DC-SIGN_rs4804800 0.6409 NS 76/100
3 MCP-1_rs4586, Dectin-1_rs3901533, Dectin-2_rs7134303 0.7085 0.025 68/100
4 MCP-1_rs4586, Dectin-1_rs3901533, CCR2_rs3918358, Dectin-2_rs7134303 0.7735 ,0.001 100/100
TA, Testing accuracy; CVC, Cross-validation consistency.
*1000-fold permutation test.
doi:10.1371/journal.pone.0032273.t004
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classification criteria, 2005 [60]. The apparent effect of these SNPs
on IPA susceptibility persisted even after adjustment for age,
gender, hematological malignancy and several known risk factors
(HSCT, neutropenia, GVHD and corticoid therapy use), indicat-
ing that Dectin-1 and DC-SIGN variants contribute independently to
the risk of infection.
Another interesting finding of this study was the significantly
greater positive GM percentage of patients carrying the Dectin-
1rs3901533_T allele than those with the wild-type allele. Additionally,
patients harboring the G/G genotype for the Dectin-1rs7903123
SNP showed an increased percentage of positive GM compared to
those carrying the C allele (C/C+C/G). No differences were found
when positive GM determinations were correlated with DC-SIGN
polymorphisms. These data along with the remarkable degree of
association of Dectin-1 and DC-SIGN variants with risk of IPA
infection provides a compelling evidence for a critical role for these
PRRs in immune response to IPA infection. In this regard,
numerous studies have shown that Dectin-1 and DC-SIGN are not
only involved in the recognition of fungal pathogens but also in the
induction of anti-fungal Th1 and Th17 immune responses [5,11].
Mezger et al. also demonstrated that Dectin-1 is involved in the
induction of several pro-inflamatory cytokines, chemokines and
immune receptors [18] while Werner et al. showed that Dectin-1 is
also regulating Th17-mediated immune response in the lungs [61].
Furthermore, Dennehy and Brown suggested a role of Dectin-1
mediating its own signaling, as well as synergizing with TLRs to
trigger NFkB-mediated immune response against fungal patho-
gens [62].
Although it is now well recognized that SNPs in genes
modulating immune response are likely to be determinants of
host susceptibility to fungal infections, so far, little is known
regarding the biological significance of these variants. In order to
shed light into the potential functionality of Dectin-1 (rs3901533
and rs7309123) and DC-SIGN (rs4804800, rs11465384, rs7248637,
rs7252229 and rs2287886) variants, we investigated whether they
were involved in disruption of a binding site for critical
transcription factors that might influence transcription level of
these genes. Our predictive analysis showed that the carriage of
the C allele for the Dectin-1rs7309123 SNP creates a putative binding
site for Cdxa, a relatively unknown transcription factor, which
might be involved in the control of Dectin-1 gene expression. To
assess whether the Dectin-1rs7309123 polymorphism might be
associated with a decreased expression of Dectin-1, we correlated
Dectin-1 mRNA expression levels with Dectin-1rs7309123 geno-
types. Interestingly, we observed that individuals harbouring the
GG genotype showed a relatively lower expression than those
carrying the C allele (CC+GC). These results further supported
our hypothesis suggesting that Dectin-1rs7309123 SNP may have an
effect on the Dectin-1-mediated recognition of Aspergillus conidia
and subsequent immune responses. However, this predicted
change in transcription activity is only suggestive at this stage
and will need further validation using in vitro functional assays.
Several lines of evidence point to the relevance of epistatic
effects in the etiology of complex diseases but, up to now, no
studies have been carried out to analyze the presence of SNP-SNP
interactions in IPA infection. For this reason, we decide to assess
interactions among genetic polymorphisms within DC-SIGN,
Dectin-1, Dectin-2, CCL2 and CCR2, genes and the risk of IPA
infection. The MDR approach used in this study was able to
determine two multilocus combinations associated with high risk
to develop IPA infection. Of the interactions identified, MDR
indicated that the type of interaction in the two significant models
was synergistic. These results support the hypothesis that multiple
SNP–SNP interactions may play a role in determining the risk of
IPA infection. This hypothesis is biologically plausible since the
immune system would warrant prevention of fungal infection even
when some genetic variants were present.
Recent population-based studies have even led to the identifi-
cation of several SNPs involved in the early recognition of
Aspergillus and associated them with an increased risk for invasive
fungal infection. It has previously been suggested that SNPs within
C-type lectin genes are associated with fungal infections. Platinga
et al. (2009) and Cunha et al. (2010) suggested that patients carrying
the Y238X (rs16910526) polymorphism in the Dectin-1 gene were
more likely to be colonized with Aspergillus and Candida species
[19,63], compared with those harboring the wild-type allele.
However, these results were not replicated in a very recent study
[24]. In our study, such findings were neither evidenced even
when HSCT and non-HSCT patients were analyzed separately
(data not shown). This puzzling finding suggests that, although
intronic polymorphisms within Dectin-1 and DC-SIGN are indeed
themselves a strong indication that these genes play an important
role in the susceptibility to IPA infection, we cannot rule out the
Figure 3. Interaction dendrogram generated by the MDR software. The interaction dendrogram was used to confirm, visualize, and interpret
the interaction model. The MDR analysis was performed by using the open-source MDR software package. The colors used depict the degree of
synergy, ranging from red (highest information gain) to blue (highest information redundancy). Note that the interaction between Dectin-1
(rs3901533) and DC-SIGN (rs4804800) SNPs showed the highest degree of synergy (gain of information).
doi:10.1371/journal.pone.0032273.g003
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containing important other genetic variants in the neighboring
genes. In any case, because all these population-based studies have
been conducted using relatively small cohorts, additional studies in
larger set of patients are needed to definitely establish the role of
these variants in the susceptibility to invasive fungal infection.
In summary, this study provides evidence of association between
Dectin-1 and DC-SIGN polymorphisms and the risk of IPA
infection. By the inclusion of functional prediction analyses, the
correlation of genotypes with positive GM determinations and
Dectin-1 mRNA expression levels, the study strongly supported
the role of Dectin-1 gene variants in determining susceptibility to
IPA infection. Epistatic analyses also suggested the presence of a
gene-gene interaction involving Dectin-1 with CCL2 and CCR2
variants to determine IPA infection. Despite all these evidences,
additional studies using larger cohorts will be necessary to confirm
the effect of these polymorphisms on the susceptibility to IPA
infection.
Supporting Information
Table S1 Associations of polymorphisms involved in the
phagocyte-immune related response against Aspergil-
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